Urgent

Nephrogenic diabetes insipidus (lithium-induced)

Water balance · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Renal resistance to vasopressin from chronic lithium therapy, causing polyuria, polydipsia and risk of hypernatraemic dehydration if water access is limited.

Red flags

  • Severe hypernatraemia
  • Reduced conscious level
  • Inability to access water
  • Concurrent lithium toxicity

Assessment

Differential diagnosis

  • Central diabetes insipidus
  • Primary polydipsia
  • Osmotic diuresis (hyperglycaemia)
  • Hypercalcaemia-related DI
  • Post-obstructive diuresis

Investigations

  • Serum sodium and osmolality
  • Urine osmolality (inappropriately dilute)
  • U&E, calcium, glucose
  • Lithium level
  • Fluid balance and urine output

Management

  • Assess hydration and sodium
  • Ensure adequate access to water / free water replacement
  • Correct hypernatraemia at a safe rate
  • Review and (with psychiatry) consider reducing/stopping lithium
  • Consider thiazide / amiloride (specialist, paradoxical benefit)
  • Endocrinology / nephrology and psychiatry input

Drugs & doses

Free water / hypotonic fluids (careful rate)
Amiloride or thiazide (specialist)
Review lithium with psychiatry

Disposition

Admit if symptomatic hypernatraemia; specialist input.

Complications & pitfalls

  • Hypernatraemic dehydration
  • Neurological injury from rapid correction
  • Persistent DI despite stopping lithium

Exam pearls

  • Correct hypernatraemia slowly to avoid cerebral oedema.
  • Amiloride can reduce lithium uptake and improve the concentrating defect.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.